NewsJanuary 15, 2025

PHC Group CEO Kyoko Deguchi Named a Top 50 Healthcare Technology CEO of 2024 by The Healthcare Technology Report — Award recognizes leaders pushing boundaries and fostering cultures of innovation in medical devices, digital health, software, and biotechnology —

TOKYO, JAPAN, January 15, 2025 – PHC Holdings Corporation (headquarters: Chiyoda-ku, Tokyo, Japan, President & CEO: Kyoko Deguchi, hereafter PHC Group), a global healthcare company dedicated to providing precision technology that powers the future of healthcare, announces that CEO Kyoko Deguchi has been named to the “Top 50 Healthcare Technology CEOs of 2024^*1” list published by The Healthcare Technology Report^*2, a leading healthcare technology industry publication.

Each year, The Healthcare Technology Report recognizes companies and executives that create innovative solutions to the most pressing issues in healthcare. The Top 50 Healthcare Technology CEOs list reflects individuals whose ability to lead through change, inspire their organizations, and innovate in the face of healthcare’s most pressing challenges has positioned their companies as leaders in the field, driving progress to improve patient care and global health.

PHC Group is comprised of a network of established companies that are leaders in their respective fields, with $2.2B in total annual revenue. PHC Group companies have been providing innovative precision and digital health solutions for more than 50 years to advance research, diagnosis, treatment, and prevention of disease. Collectively, PHC Group seeks to provide precision technology that powers the future of healthcare.

Deguchi joined PHC Group as an independent external board director in 2021, bringing over two decades of experience as a business leader, including in the healthcare industry. She became CEO in April 2024, and in her first six months launched an updated vision and value creation plan outlining PHC Group’s new global strategy to focus future growth on diagnostics and life sciences. During this time, Deguchi focused on building an inclusive and collaborative workforce, including conducting a global tour of roundtables with more than 500 employees across PHC Group’s subsidiaries.

As PHC Group’s first female CEO, Deguchi is a modern leader for an increasingly diverse company and industry. She prioritizes inclusion and is a vocal proponent of the concept of “One PHC,” a company mindset that seeks to create synergies across divisions and disciplines to create greater value for researchers, healthcare providers, and the patients they serve.

*1 https://thehealthcaretechnologyreport.com/
*2 https://thehealthcaretechnologyreport.com/the-top-50-healthcare-technology-ceos-of-2024/

About PHC Holdings Corporation (PHC Group)

PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia Holdings Ltd., LSI Medience Corporation, Wemex Corporation, and Mediford Corporation.Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group’s consolidated net sales in FY2023 were JPY 353.9 billion with global distribution of products and services in more than 125 countries.
www.phchd.com